Ted is an accomplished life science executive with 25+ years of experience helping teams translate science into enterprise value, from early development through launch and lifecycle management. Prior to joining Danforth, he served as CEO, CBO, and board member at Pulmatrix, where he advanced the development pipeline through strategic financings and partnerships.

Ted’s previous roles include CCO at Option Care, VP of Home Infusion Sales & Marketing at Walgreens, VP of Sales & Marketing at Sunovion Pharmaceuticals, and Regional Sales Director at Novartis. He currently serves on the board of directors for Oxeia Biopharmaceuticals.

Ted holds an MBA from Thunderbird School of Global Management and a BS in Business Administration from the University of Colorado.

Select Accomplishments

• Secured $75 million in capital markets financing and more than $50 million in partnerships funding as CEO of Pulmatrix.
• As part of the executive team, spun out Walgreens’ $1.5 billion home drug infusion business to private equity, forming Option Care, the largest US home infusion provider.